Vanguard Global Advisers »

Aziyo Biologics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5k 8.1k 1.05

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Silverarc Capital Management
Knollwood Investment Advisory
Vanguard Group
Vanguard Capital Management
Perkins Capital Management
Geode Capital Management
CI Private Wealth
Birchview Capital
BlackRock
Rossmore Private Capital
Vanguard Fiduciary Trust
Citadel Advisors
XTX Topco

View all funds holding Aziyo Biologics